Interestingly, we observed that all eight patients who developed IBTR in the IORT-E group had adverse biological risk factors: high histological grade, ki67 value >20, and invasive lobular carcinoma, while no patients with a luminal A tumor suffered relapse. The gene discussed is MKI67; the disease is invasive lobular breast carcinoma.